Overview
Acromesomelic dysplasia, Grebe type (also known as Grebe chondrodysplasia or Brazilian achondrodysplasia) is a rare, severe skeletal disorder characterized by marked shortening and malformation of the limbs, particularly affecting the middle (mesomelic) and distal (acromelic) segments. The condition follows a characteristic proximal-to-distal gradient of severity, meaning the hands and feet are more severely affected than the forearms and lower legs, which in turn are more affected than the upper arms and thighs. The hands and feet may show extremely short, malformed digits (brachydactyly) or even rudimentary, ball-shaped digits with fusion of finger and toe bones (synostosis). The long bones of the limbs are shortened and often bowed, while the axial skeleton (spine and trunk) is relatively spared, resulting in a disproportionately short-limbed stature. This condition is caused by homozygous or compound heterozygous mutations in the GDF5 gene (also known as CDMP1), which encodes growth/differentiation factor 5, a member of the bone morphogenetic protein family critical for cartilage and bone development. The GDF5 protein plays an essential role in limb morphogenesis and joint formation. Loss-of-function mutations in this gene disrupt normal skeletal patterning, particularly in the appendicular skeleton. The condition was first described in a large consanguineous family in Brazil by Grebe in 1952. There is currently no cure or disease-specific treatment for Grebe type acromesomelic dysplasia. Management is supportive and symptomatic, focusing on orthopedic interventions to address limb deformities and improve mobility, physical therapy, and adaptive devices to assist with daily activities. Genetic counseling is recommended for affected families. Intelligence and life expectancy are typically normal. Early diagnosis can be made prenatally or at birth based on clinical and radiographic findings, and molecular genetic testing of the GDF5 gene can confirm the diagnosis.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Acromesomelic dysplasia, Grebe type.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Acromesomelic dysplasia, Grebe type at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Acromesomelic dysplasia, Grebe type.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Acromesomelic dysplasia, Grebe type.
Community
No community posts yet. Be the first to share your experience with Acromesomelic dysplasia, Grebe type.
Start the conversation →Latest news about Acromesomelic dysplasia, Grebe type
No recent news articles for Acromesomelic dysplasia, Grebe type.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Acromesomelic dysplasia, Grebe type
What is Acromesomelic dysplasia, Grebe type?
Acromesomelic dysplasia, Grebe type (also known as Grebe chondrodysplasia or Brazilian achondrodysplasia) is a rare, severe skeletal disorder characterized by marked shortening and malformation of the limbs, particularly affecting the middle (mesomelic) and distal (acromelic) segments. The condition follows a characteristic proximal-to-distal gradient of severity, meaning the hands and feet are more severely affected than the forearms and lower legs, which in turn are more affected than the upper arms and thighs. The hands and feet may show extremely short, malformed digits (brachydactyly) or
How is Acromesomelic dysplasia, Grebe type inherited?
Acromesomelic dysplasia, Grebe type follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Acromesomelic dysplasia, Grebe type typically begin?
Typical onset of Acromesomelic dysplasia, Grebe type is neonatal. Age of onset can vary across affected individuals.